Position in NKTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$129,395
-$32,287 QoQ
Shares Held
45,723
-40.3% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. NKTX ranks #268 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129,395 | 45,723 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $161,682 | 76,627 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,912 | 2,115 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $53,273 | 25,736 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $97,627 | 58,812 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $108,214 | 58,812 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $107,460 | 43,157 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $154,632 | 34,211 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $103,205 | 17,463 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $216,253 | 20,005 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $212,486 | 32,195 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,443 | 6,794 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $39,623 | 18,093 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $144,910 | 40,820 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $184,731 | 30,840 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $415,632 | 31,583 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $218,186 | 17,710 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $114,197 | 10,035 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $131,334 | 8,556 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $225,650 | 8,114 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $265,403 | 8,375 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $443,096 | 13,468 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $900,288 | 14,646 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $261,220 | 8,690 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||